Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab
This study has been completed.
Study NCT00510536   Information provided by Probity Medical Research

First Received on August 1, 2007.   Last Updated on April 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Arthritis
Arthralgia
Additional conditions recognized in this trial
Psoriasis
More general conditions related to this trial
Joint Diseases
Musculoskeletal Diseases
Pain
Signs and Symptoms
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
Acetaminophen
NSAID
Additional drug interventions recognized in this trial
Anti-Inflammatory Agents, Non-Steroidal
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Antipyretics
Antirheumatic Agents
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Probity Medical Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services